Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
First synthesized at the University of Arizona in the 1980s, MT1 is currently being studied for its potential to aid in mitigating skin disorders
BENEFITS & CLINICAL TRIALS The primary research focus is the acceleration of recovery and healing of soft tissue and the reduction of inflammation
Int J Biol Macromol (2018) 112:53747
Related Products Sequence: 16-aa peptide Structure: Linear Formula: CHNOS Purity: 96.9% Ingrediants: Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-Tyr $46.00 Sequence: 37-aa peptide Structure: Linear Formula: CHNOS Purity: 99.79% Ingrediants: Long-acting amylin analog
US$ 24.01
US$ 22.01
US$ 21.07
US$ 21.10
US$ 29.95
US$ 21.49
